1 |
Andersen P. TB vaccines: progress and problems. Trends Immunol. 2001. 22: 160-168.
DOI
ScienceOn
|
2 |
Banerjee R, Rudra R, Prajapati RK, Sengupta S, Mukhopadhya J. Optimization of recombinant Mycobacterium tuberculosis RNA polymerase expression and purification. Tuberculosis. 2014. 94: 397-404.
DOI
|
3 |
Borukhov S, Nudler E. RNA polymerase holoenzyme: structure, function and biological implications. Curr Opin Microbiol. 2003. 6: 93-100.
DOI
ScienceOn
|
4 |
Chefalo PJ, Grandea AG 3rd, Van Kaer L, Harding CV. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J Immunol. 2003. 170: 5825-5833.
DOI
|
5 |
Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, Flynn JL, Barnes PF, Southwood S, Celis E, Bloom BR, Modlin RL, Sette A. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A. 2000. 97: 12210-12215.
DOI
|
6 |
Grotzke JE, Siler AC, Lewinsohn DA, Lewinsohn DM. Secreted immunodominant Mycobacterium tuberculosis antigens are processed by the cytosolic pathway. J Immunol. 2010. 185: 4336-4343.
DOI
|
7 |
Harriff MJ, Purdy GE, Lewinsohn DM. Escape from the Phagosome: The Explanation for MHC-I Processing of Mycobacterial Antigens. Front Immunol. 2012. 3: 1-11.
|
8 |
Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNAbb AL, Streblow DN, Braud VM, Grieser HJ, Belisle JT, Lewinsohn DM. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med. 2002. 196: 1473-1481.
DOI
|
9 |
Koch R. Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882. Rev Infect Dis. 1982. 4: 1270-11274.
DOI
|
10 |
Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG, Grabstein KH. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigenpresenting cells. J Exp Med. 1998. 187: 1633-1640.
DOI
ScienceOn
|
11 |
Mazzaccaro RJ, Stenger S, Rock KL, Porcelli SA, Brenner MB, Modlin RL, Bloom BR. Cytotoxic T lymphocytes in resistance to tuberculosis. Adv Exp Med Biol. 1998. 452: 85-101.
DOI
|
12 |
Mariani F, Cappelli G, Riccardi G, Colizzi V. Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage. Gene 2000. 253: 281-291.
DOI
|
13 |
Moore M Onorato IM, McCray E, Castro KG. Trends in drugresistant tuberculosis in the United States, 1993-1996. JAMA 1997. 278: 833-837.
DOI
|
14 |
Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, Modlin RL, Brinkmann V, Kaufmann SH. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med. 2003. 9: 1039-1046.
DOI
ScienceOn
|
15 |
Smith SM, Malin AS, Pauline T, Lukey, Atkinson SE, Content J, Huygen K, Dockrell HM. Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun. 1999. 67: 5223-5230.
|
16 |
Tobian AA, Potter NS, Ramachandra L, Pai RK, Convery M, Boom WH, Harding CV. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol. 2003. 171: 1413-1422.
DOI
|
17 |
Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, Hongi S, Van Kaeri L, Bloom BR. Relative contributions of distinct MHC class I-dependent cell populations in protection of tuberculosis infection in mice. Proc Natl Acad Sci U S A. 2000. 97: 4204-4208.
DOI
|
18 |
Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK, Rich EA. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol. 1997. 159: 290-297.
|
19 |
Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nat Med. 1996. 2: 888-892.
DOI
|
20 |
Tobian AA, Canaday DH, Boom WH, Harding CV. Bacterial heat shock proteins promote CD91-dependent class I MHC crosspresentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. J Immunol. 2004. 172: 5277-5286.
DOI
|
21 |
Turner J, Dockrell HM. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 1996. 87: 339-342.
DOI
|
22 |
Wayne LG. Microbiology of tubercle bacilli. Am Rev Respir Dis. 1982. 125: 31-41.
|
23 |
WHO Global Tuberculosis Control Report 2010. Summary. Cent Eur J Publ Health, 2010. 18: 237.
DOI
|